Try our beta test site
155 studies found for:    "Meningioma"
Show Display Options
Rank Status Study
21 Not yet recruiting A Trial of Pembrolizumab for Refractory Atypical and Anaplastic Meningioma
Conditions: Atypical Meningioma;   Anaplastic Meningioma;   Hemangiopericytoma
Intervention: Drug: Pembrolizumab
22 Completed Combination of Hydroxyurea and Verapamil for Refractory Meningiomas
Conditions: Cancer;   Brain Cancer;   Meningioma
Interventions: Drug: Hydroxyurea;   Drug: Verapamil
23 Not yet recruiting Oncological Care for Patients With Meningioma
Conditions: Atypical Meningioma;   Clear-cell Meningioma;   Chordoid Meningioma;   Anaplastic Meningioma;   Rhabdoid Meningioma;   Papillary Meningioma
Intervention:
24 Not yet recruiting Effects of Scalp Nerve Blocks on Systemic Inflammation
Condition: Meningiomas
Interventions: Procedure: Scalp Nerve Blocks With Ropivacaine;   Procedure: Scalp Nerve Blocks With Saline
25 Recruiting AZD2014 In NF2 Patients With Progressive or Symptomatic Meningiomas
Conditions: Neurofibromatosis 2;   Meningioma
Intervention: Drug: AZD2014
26 Withdrawn Vascular Endothelial Growth Factor (VEGF) Levels in Brain Tumor Patients
Conditions: Glioma;   Meningioma
Intervention: Procedure: Blood test
27 Recruiting Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
Conditions: Anaplastic (Malignant) Meningioma;   Atypical Meningioma;   Grade II Meningioma;   Grade III Meningioma;   Recurrent Meningioma;   Supratentorial Meningioma
Interventions: Biological: Bevacizumab;   Procedure: Electric Field Therapy;   Device: NovoTTF-100A Device;   Procedure: Quality-of-Life Assessment
28 Completed Information Presentation Formats
Condition: Meningioma
Interventions: Other: Check Symptoms;   Other: Uncheck Symptoms;   Other: Experienced;   Other: Not Experienced
29 Terminated
Has Results
Phase II Study of SOM230 in Patients With Recurrent or Progressive Meningioma
Condition: Cancer
Intervention: Drug: SOM230B
30 Completed Imatinib Mesylate in Treating Patients With Recurrent Meningioma
Conditions: Adult Grade I Meningioma;   Adult Grade II Meningioma;   Adult Grade III Meningioma;   Adult Meningeal Hemangiopericytoma;   Adult Meningioma;   Recurrent Adult Brain Tumor
Interventions: Drug: imatinib mesylate;   Other: laboratory biomarker analysis;   Other: pharmacological study
31 Recruiting Exploring the Activity of RAD001 in Vestibular Schwannomas and Meningiomas
Conditions: Neurofibromatosis Type 2;   Vestibular Schwannomas;   Meningiomas
Intervention: Drug: RAD001
32 Recruiting Exploratory Evaluation of AR-42 Histone Deacetylase Inhibitor in the Treatment of Vestibular Schwannoma and Meningioma
Conditions: Vestibular Schwannoma;   Meningioma;   Acoustic Neuroma;   Neurofibromatosis Type 2
Intervention: Drug: AR-42
33 Active, not recruiting Pilot Study of Optune (NovoTTF-100A) for Recurrent Atypical and Anaplastic Meningioma
Condition: Brain Cancer
Intervention: Device: Optune (NovoTTF-100A)
34 Completed Radiation Therapy in Treating Patients Who Have Undergone Surgery for Newly Diagnosed Grade II or Grade III Meningioma
Condition: Brain and Central Nervous System Tumors
Interventions: Procedure: adjuvant therapy;   Radiation: radiation therapy
35 Terminated Radiotherapy or Radiosurgery Compared With Observation Alone in Treating Patients With Newly Diagnosed, Benign Meningioma That Has Been Partially Removed by Surgery
Condition: Brain and Central Nervous System Tumors
Interventions: Procedure: adjuvant therapy;   Radiation: radiation therapy;   Radiation: stereotactic radiosurgery
36 Completed
Has Results
Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma
Conditions: CNS Cancer;   Meningioma;   Intracranial Hemangiopericytoma;   Hemangioblastoma;   Neurofibromatosis
Intervention: Drug: Sunitinib
37 Unknown  Hydroxyurea in Treating Patients With Recurrent and/or Unresectable Meningioma
Condition: Brain and Central Nervous System Tumors
Intervention: Drug: hydroxyurea
38 Unknown  Hydroxyurea With or Without Imatinib Mesylate in Treating Patients With Recurrent or Progressive Meningioma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: hydroxyurea;   Drug: imatinib mesylate
39 Completed
Has Results
Vatalanib in Treating Patients With Recurrent or Progressive Meningioma
Conditions: Brain and Central Nervous System Tumors;   Sarcoma
Intervention: Drug: vatalanib
40 Active, not recruiting Observation or Radiation Therapy in Treating Patients With Grade I, Grade II, or Grade III Meningioma
Condition: Brain and Central Nervous System Tumors
Interventions: Other: clinical observation;   Radiation: 3-dimensional conformal radiation therapy;   Radiation: intensity-modulated radiation therapy (IMRT)

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.